Wilson Sonsini Goodrich & Rosati advised Cimeio Therapeutics on the transaction. Cimeio Therapeutics, an immunotherapy company, announced that it has entered a research collaboration with Kyowa...
You must be a Standard 1 Year member to access this content.
Ropes & Gray represented AvenCell Therapeutics in the transaction, and Wilson Sonsini Goodrich & Rosati advised Novo Holdings and F-Prime Capital on the transaction. AvenCell Therapeutics...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Borealis Biosciences on the transaction. Borealis Biosciences (Borealis), a next-generation RNA medicines company, emerged from stealth with $150 million in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Fluent Biosciences on the transaction. Illumina, Inc. (NASDAQ: ILMN) announced it has acquired Fluent BioSciences (Fluent), developer of an emerging...
You must be a Standard 1 Year member to access this content.
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Radar Therapeutics on the deal, and Wilson Sonsini Goodrich & Rosati advised Radar Therapeutics on IP matters related...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised SR One, Norwest Venture Partners, and Delos Capital on the transaction. Zenas BioPharma, a clinical-stage global biopharmaceutical company, announced an...
You must be a Standard 1 Year member to access this content.
King & Spalding has secured USD $900 million dollars for Reficar in its long running dispute with CB&I. The dispute with CB&I, owned by McDermott International since...
You must be a Standard 1 Year member to access this content.
King & Spalding has secured USD $900 million dollars for Reficar in its long running dispute with CB&I. The dispute with CB&I, owned by McDermott International since...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Tempo Therapeutics in the transaction. Tempo Therapeutics, Inc. (“Tempo”) announced the completion of a $12 million Series A equity financing round, led by...
You must be a Standard 1 Year member to access this content.
King & Spalding assisted Électricité de France and Masdar on the concession agreement. EDF (Électricité de France), French multinational electric utility company, and Masdar, leading clean...
You must be a Standard 1 Year member to access this content.
King & Spalding advised Tradeshift on the joint venture with HSBC. Tradeshift raised $70 million to scale its business network, investing in the addition of more SaaS,...
You must be a Standard 1 Year member to access this content.
Travers Smith LLP has advised SSP Group on the deal. Interpath Advisory was advised by DLP Piper LLP. SSP Group acquired AMT Coffee from its administrators...
You must be a Standard 1 Year member to access this content.
